Brian C. Betts, MD, discusses how discharging patients as early as day 5 after stem cell transplant has proved feasible and improves quality of life.
Brian C. Betts, MD
Advertisement
Brian C. Betts, MD, is Vice Chair of Strategic Initiatives for the Transplant & Cellular Therapy Program at Roswell Park Comprehensive Cancer Center.
Articles by Brian C. Betts, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
Behind the FDA Approval: Isatuximab On-Body Injector Supports ‘Patient-Centric’ Priorities in Multiple Myeloma
2
Safusidenib Shows Durable Responses in IDH1-Mutant Glioma at 3-Year Follow-Up
3
CheckMate 9LA Data Push Toward Dual Checkpoint Blockade in PD-L1–Negative NSCLC
4
Thoracic Radiotherapy Added to Atezolizumab Raised Toxicity in SCLC
5